Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-24 @ 4:46 PM
NCT ID:
NCT02904850
Eligibility Criteria:
Inclusion Criteria:
* All patients receiving treatment with erlotinib monotherapy for locally advanced or metastatic NSCLC either first line in patients with an activating mutation of the receptor EGF-R or patients with stable disease after 4 cycles of standard first-line chemotherapy with platinum or after failure of at least one prior chemotherapy regimen
* Age\> 18 years
* Subject has signed an informed consent
* Treatment initiated for at least 7 days or dosage changed for at least 7 days
Exclusion Criteria:
* Contraindication to the use of drug
* Subject to exclusion period (as determined by a previous study or in progress)
* Inability to give informed information (subject in emergency situations, difficulties in understanding the subject, ...)
* Subject under judicial protection
* Subject under tutorship or curatorship
* Pregnancy (and woman of childbearing age without contraception)
* Breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02904850
Study Brief:
Protocol Section:
NCT02904850